These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
753 related articles for article (PubMed ID: 27354785)
21. Impact of exacerbations on respiratory system impedance measured by a forced oscillation technique in COPD: a prospective observational study. Kamada T; Kaneko M; Tomioka H Int J Chron Obstruct Pulmon Dis; 2017; 12():509-516. PubMed ID: 28223791 [TBL] [Abstract][Full Text] [Related]
22. Therapy with proton-pump inhibitors for gastroesophageal reflux disease does not reduce the risk for severe exacerbations in COPD. Baumeler L; Papakonstantinou E; Milenkovic B; Lacoma A; Louis R; Aerts JG; Welte T; Kostikas K; Blasi F; Boersma W; Torres A; Rohde GG; Boeck L; Rakic J; Scherr A; Tamm M; Stolz D Respirology; 2016 Jul; 21(5):883-90. PubMed ID: 26970108 [TBL] [Abstract][Full Text] [Related]
23. Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease. Perez T; Burgel PR; Paillasseur JL; Caillaud D; Deslée G; Chanez P; Roche N; Int J Chron Obstruct Pulmon Dis; 2015; 10():1663-72. PubMed ID: 26316740 [TBL] [Abstract][Full Text] [Related]
24. Examining the Effects of Age on Health Outcomes of Chronic Obstructive Pulmonary Disease: Results From the Genetic Epidemiology of Chronic Obstructive Pulmonary Disease Study and Evaluation of Chronic Obstructive Pulmonary Disease Longitudinally to Identify Predictive Surrogate Endpoints Cohorts. Parulekar AD; Martinez C; Tsai CL; Locantore N; Atik M; Yohannes AM; Kao CC; Al-Azzawi H; Mohsin A; Wise RA; Foreman MG; Demeo DL; Regan EA; Make BJ; Boriek AM; Wiener LE; Hanania NA J Am Med Dir Assoc; 2017 Dec; 18(12):1063-1068. PubMed ID: 29169736 [TBL] [Abstract][Full Text] [Related]
25. "Frequent exacerbator" is a phenotype of poor prognosis in Japanese patients with chronic obstructive pulmonary disease. Tomioka R; Kawayama T; Suetomo M; Kinoshita T; Tokunaga Y; Imaoka H; Matsunaga K; Okamoto M; Hoshino T Int J Chron Obstruct Pulmon Dis; 2016; 11():207-16. PubMed ID: 26893552 [TBL] [Abstract][Full Text] [Related]
26. Physiologic variables and functional status independently predict COPD hospitalizations and emergency department visits in patients with severe COPD. Fan VS; Ramsey SD; Make BJ; Martinez FJ COPD; 2007 Mar; 4(1):29-39. PubMed ID: 17364675 [TBL] [Abstract][Full Text] [Related]
27. A score to predict short-term risk of COPD exacerbations (SCOPEX). Make BJ; Eriksson G; Calverley PM; Jenkins CR; Postma DS; Peterson S; Östlund O; Anzueto A Int J Chron Obstruct Pulmon Dis; 2015; 10():201-9. PubMed ID: 25670896 [TBL] [Abstract][Full Text] [Related]
28. Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting β2-agonist fixed-dose combination: RE(2)SPOND rationale and study design. Rennard SI; Martinez FJ; Rabe KF; Sethi S; Pizzichini E; McIvor A; Siddiqui S; Anzueto A; Zhu H Int J Chron Obstruct Pulmon Dis; 2016; 11():1921-8. PubMed ID: 27574416 [TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of twice-daily glycopyrrolate in patients with stable, symptomatic COPD with moderate-to-severe airflow limitation: the GEM1 study. LaForce C; Feldman G; Spangenthal S; Eckert JH; Henley M; Patalano F; D'Andrea P Int J Chron Obstruct Pulmon Dis; 2016; 11():1233-43. PubMed ID: 27354782 [TBL] [Abstract][Full Text] [Related]
30. Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease. Dransfield MT; Kunisaki KM; Strand MJ; Anzueto A; Bhatt SP; Bowler RP; Criner GJ; Curtis JL; Hanania NA; Nath H; Putcha N; Roark SE; Wan ES; Washko GR; Wells JM; Wendt CH; Make BJ; Am J Respir Crit Care Med; 2017 Feb; 195(3):324-330. PubMed ID: 27556408 [TBL] [Abstract][Full Text] [Related]
31. In-hospital and one-year mortality and their predictors in patients hospitalized for first-ever chronic obstructive pulmonary disease exacerbations: a nationwide population-based study. Ho TW; Tsai YJ; Ruan SY; Huang CT; Lai F; Yu CJ; PLoS One; 2014; 9(12):e114866. PubMed ID: 25490399 [TBL] [Abstract][Full Text] [Related]
32. Anxiety and depression among dairy farmers: the impact of COPD. Guillien A; Laurent L; Soumagne T; Puyraveau M; Laplante JJ; Andujar P; Annesi-Maesano I; Roche N; Degano B; Dalphin JC Int J Chron Obstruct Pulmon Dis; 2018; 13():1-9. PubMed ID: 29296078 [TBL] [Abstract][Full Text] [Related]
33. Deterioration of quality of life is associated with the exacerbation frequency in individuals with alpha-1-antitrypsin deficiency - analysis from the German Registry. Bernhard N; Lepper PM; Vogelmeier C; Seibert M; Wagenpfeil S; Bals R; Fähndrich S Int J Chron Obstruct Pulmon Dis; 2017; 12():1427-1437. PubMed ID: 28553095 [TBL] [Abstract][Full Text] [Related]
34. Prevention of clinically important deteriorations in COPD with umeclidinium/vilanterol. Singh D; Maleki-Yazdi MR; Tombs L; Iqbal A; Fahy WA; Naya I Int J Chron Obstruct Pulmon Dis; 2016; 11():1413-24. PubMed ID: 27445468 [TBL] [Abstract][Full Text] [Related]
35. Association between lung function and exacerbation frequency in patients with COPD. Hoogendoorn M; Feenstra TL; Hoogenveen RT; Al M; Mölken MR Int J Chron Obstruct Pulmon Dis; 2010 Dec; 5():435-44. PubMed ID: 21191438 [TBL] [Abstract][Full Text] [Related]
36. Treatment burden, clinical outcomes, and comorbidities in COPD: an examination of the utility of medication regimen complexity index in COPD. Negewo NA; Gibson PG; Wark PA; Simpson JL; McDonald VM Int J Chron Obstruct Pulmon Dis; 2017; 12():2929-2942. PubMed ID: 29062230 [TBL] [Abstract][Full Text] [Related]
37. Comparison of COPD Assessment Test and Clinical COPD Questionnaire to predict the risk of exacerbation. Jo YS; Yoon HI; Kim DK; Yoo CG; Lee CH Int J Chron Obstruct Pulmon Dis; 2018; 13():101-107. PubMed ID: 29317814 [TBL] [Abstract][Full Text] [Related]
38. A year in the life of German patients with COPD: the DACCORD observational study. Buhl R; Criée CP; Kardos P; Vogelmeier C; Lossi N; Mailänder C; Worth H Int J Chron Obstruct Pulmon Dis; 2016; 11():1639-46. PubMed ID: 27499620 [TBL] [Abstract][Full Text] [Related]
40. Comparison of disease-severity measures within severe and very severe COPD patients: results from a nationally representative chart review and patient survey. Solem CT; Sun SX; Liu S; Macahilig C; Katyal M; Gao X; Shorr AF Int J Chron Obstruct Pulmon Dis; 2014; 9():991-8. PubMed ID: 25284999 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]